(Reuters) — Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments ...

Merck has struck a $1.3 billion deal to buy Eyebiotech, a move that would push the big drugmaker into the large and growing market for eye-care. Under the terms, Merck would pay the $1.3 billion ...

May 28 (Reuters) - Merck & Co (MRK.N), opens new tab is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 ...

FILE PHOTO: Signage is seen at the Merck & Co. headquarters in Kenilworth ... Bill Gates Says He Donated $100 Billion Of His Wealth To Charitable Causes, But He 'Didn't Order Less Hamburgers ...

(Reuters) — Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the ...

Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports ...